Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Commentary: Overcoming "Founders' Syndrome" to find start-up success

This article was originally published in Scrip

Executive Summary

The current downturn has done little to dampen our naturally entrepreneurial spirit, and if we look around the life sciences sector today there is no shortage of inventive people willing to risk everything they have on that next great drug discovery. However, global research shows that for every 20 life sciences start-ups that get off the ground, 19 fail to stay in the air; never reaching commercial viability, let alone business maturity. Nick Stephens, CEO of global life sciences recruitment specialists RSA, offers insight into why so many promising companies fail, and what can be done to avoid this all too familiar fate.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts